Joseph S. Zakrzewski - May 10, 2022 Form 4 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role
Director
Signature
/s/ Adam M. Veness, as attorney-in-fact for Joseph Zakrzewski
Stock symbol
CYT
Transactions as of
May 10, 2022
Transactions value $
$95,077
Form type
4
Date filed
5/12/2022, 04:35 PM
Previous filing
Mar 31, 2022
Next filing
May 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYT Common Stock Purchase $93.4K +49.4K +60.06% $1.89 132K May 10, 2022 Direct F1, F2
transaction CYT Common Stock Purchase $1.7K +1K +0.76% $1.70 133K May 11, 2022 Direct F2
holding CYT Common Stock 58.7K May 10, 2022 See Footnote F3
holding CYT Common Stock 149K May 10, 2022 See Footnote F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $1.67 to $2.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2 55,102 of the shares of common stock held directly and indirectly by the Reporting Person were acquired upon early exercise of an option and are subject to forfeiture until they vest.
F3 Shares held by Z Investments, LLC, of which the Reporting Person is the Managing Director. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
F4 Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.